Ahn, M., Kim, S., Cho, B., Ahn, J. S., Lee, D. H., Sun, J., . . . Park, K. (2014). Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press.
Citação norma ChicagoAhn, Myung-Ju, et al. Phase II Study of Afatinib As Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press, 2014.
MLA CitationAhn, Myung-Ju, et al. Phase II Study of Afatinib As Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.